This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ladas, E. J. Articles by Kelly, K. M. Search for Related Content PubMed PubMed Citation Articles by Ladas, E. J. Articles by Kelly, K. M. Social Bookmarking                            What's this?

Antioxidants and Cancer Therapy: A Systematic Review

From the Division of Pediatric Oncology, Children’s Hospital of New York; Division of Epidemiology, Joseph L. Mailman School of Public Health; Department of Pediatrics, College of Physicians and Surgeons of Columbia University, Columbia University, New York, NY.

Address reprint requests to Kara M. Kelly, MD, Columbia University, Pediatric Oncology, 161 Ft Washington, 7th floor, New York, NY 10032; e-mail: kk291{at}columbia.edu

PURPOSE: Many patients with cancer take antioxidant nutritional supplements during cancer treatment to alleviate treatment toxicities and to improve long-term outcomes, but little is known about the efficacy and safety of antioxidant use during cancer treatment. We reviewed English-language manuscripts published in the biomedical literature, reporting the results of observational studies of antioxidant status and cancer outcomes and of intervention trials of antioxidants among patients receiving chemotherapy with or without radiation for various malignancies.

METHODS: We searched the Medline database and the bibliographies of the retrieved manuscripts, reviews, and books on antioxidants and cancer. The retrieved studies are grouped by study design, malignancy, and end points.

RESULTS: More than 100 citations were retrieved; 52 met our criteria, 31 were observational studies, and 21 were intervention trials. The studies varied in study design, timing of observation/intervention, intervention protocol, malignancy, and anticancer regimen.

CONCLUSION: These inconsistencies preclude a definitive conclusion as to the effect of chemotherapy on antioxidant status in patients undergoing anticancer therapy. However, our review suggests that total antioxidant status (measured by total radical antioxidant parameter) declines during cancer treatment. Adequately powered trials or observational studies among patients with a specific cancer diagnosis receiving a specific treatment regimen are needed to address patients' and physicians' concerns regarding these associations.

Authors' disclosures of potential conflicts of interest are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				N. Sharifi Commentary: Antioxidants for Cancer: New Tricks for an Old Dog? Oncologist, March 1, 2009; 14(3): 213 - 215. [Abstract] [Full Text] [PDF]

				L. Gianni, E. H. Herman, S. E. Lipshultz, G. Minotti, N. Sarvazyan, and D. B. Sawyer Anthracycline Cardiotoxicity: From Bench to Bedside J. Clin. Oncol., August 1, 2008; 26(22): 3777 - 3784. [Abstract] [Full Text] [PDF]

				B. D. Lawenda, K. M. Kelly, E. J. Ladas, S. M. Sagar, A. Vickers, and J. B. Blumberg Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy? J Natl Cancer Inst, June 4, 2008; 100(11): 773 - 783. [Abstract] [Full Text] [PDF]

				C. M. Velicer and C. M. Ulrich Vitamin and Mineral Supplement Use Among US Adults After Cancer Diagnosis: A Systematic Review J. Clin. Oncol., February 1, 2008; 26(4): 665 - 673. [Abstract] [Full Text] [PDF]

				J. Nickerson-Troy, K. Morse, R. White, A. Beals, M. Hudson, and K. Kuczmarski State of the Art Review: Pharmacists' Approach to Selecting Dietary/Nutritional Supplements for Patients American Journal of Lifestyle Medicine, December 1, 2007; 1(6): 490 - 498. [Abstract] [PDF]

				F. J. Hlubocky, M. J. Ratain, M. Wen, and C. K. Daugherty Complementary and Alternative Medicine Among Advanced Cancer Patients Enrolled on Phase I Trials: A Study of Prognosis, Quality of Life, and Preferences for Decision Making J. Clin. Oncol., February 10, 2007; 25(5): 548 - 554. [Abstract] [Full Text] [PDF]

				C. B. Ambrosone, T. R. Rebbeck, G. J. Morgan, K. S. Albain, E. E. Calle, W. E. Evans, D. F. Hayes, L. H. Kushi, H. L. McLeod, J. H. Rowland, et al. New Developments in the Epidemiology of Cancer Prognosis: Traditional and Molecular Predictors of Treatment Response and Survival. Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2042 - 2046. [Full Text] [PDF]

				I. Bairati, F. Meyer, M. Gelinas, A. Fortin, A. Nabid, F. Brochet, J.-P. Mercier, B. Tetu, F. Harel, B. Abdous, et al. Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients J. Clin. Oncol., August 20, 2005; 23(24): 5805 - 5813. [Abstract] [Full Text] [PDF]

				D. S. Rosenthal and E. Dean-Clower Integrative Medicine in Hematology/Oncology: Benefits, Ethical Considerations, and Controversies Hematology, January 1, 2005; 2005(1): 491 - 497. [Abstract] [Full Text] [PDF]

				G. Minotti, P. Menna, E. Salvatorelli, G. Cairo, and L. Gianni Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity Pharmacol. Rev., June 1, 2004; 56(2): 185 - 229. [Abstract] [Full Text] [PDF]